Pharmaceuticals
Allergan to sell US distribution unit Anda to Teva for $500 mn
04 Aug 2016
The sale comes just a day after Teva completed its $40.5-billion acquisition of Allergan’s generic unit, following US regulatory approval a week ago
PE firm Advent in talks to buy inVentiv for nearly $4 bn
01 Aug 2016
Advent has so far prevailed over rival buyout firm CVC Capital Partners in bidding for inVentiv, one of the largest pharmaceutical contract research organisations in the US
